本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

中嘉国际

0.465
-0.020-4.12%
成交量:2,000.00
成交额:930.00
市值:1,474.05万
市盈率:9.38
高:0.465
开:0.465
低:0.465
收:0.485
数据加载中...

公司资料

公司名字:
中嘉国际
交易所:
SGX
成立时间:
1996
员工人数:
1096
公司地址:
5 Kallang Sector,#03-02,Singapore,Singapore
邮编:
349279
电话:
传真:
65 6743 7916
简介:
Pharmesis International Ltd. is a Singapore-based investment holding company. The Company is a pharmaceutical company engaged in the manufacturing of pharmaceutical products, including western medicine in the form of tablets and granules, among others, and traditional Chinese medicine (TCM) formulated products for the treatment of illnesses relating to the liver and gall bladder. It operates in three segments: Western drugs, which refers mainly to chemically formulated drugs marketed under the Kinna brand; TCM formulated drugs, which includes TCM marketed under the Longlife brand, and Distribution, which includes agency products and internally manufactured products marketed through the distribution arm. Its main products are ATT, Gulin Gansu and Er Ding granules. Its subsidiary, Chengdu Kinna Pharmaceutical Co., Ltd, is engaged in the development, manufacture, packaging and sale of western medicines and health tonic products.